Science & Technology
Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44DK136492-01A1
Award Ceiling
$2.1M
Award Floor
$2.1M
Close Date
Jul 31, 2025
Total Funding
$2.1M
Expected Awards
1
Posted Date
Sep 20, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R44DK136492-01A1
Description
SBIR Phase Phase II award: "Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy" awarded to PURE GREEN PHARMACEUTICALS, INC. in West Bloomfield, Michigan. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,051,325. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.